GRAFT FAILURE
Clinical trials for GRAFT FAILURE explained in plain language.
Never miss a new study
Get alerted when new GRAFT FAILURE trials appear
Sign up with your email to follow new studies for GRAFT FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a single dose of tocilizumab clear the way for a second kidney transplant?
Disease control CompletedThis phase 2 pilot study tested whether a single dose of tocilizumab, given before or after removing a failed kidney transplant, is safe and can reduce harmful antibodies that make a second transplant difficult. The study involved 18 adults who needed their kidney graft removed a…
Matched conditions: GRAFT FAILURE
Phase: PHASE2 • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New Blood-Cleansing method boosts transplant success in High-Risk patients
Disease control CompletedThis study looked at 50 patients who needed a stem cell transplant from a partially matched donor but had antibodies that could attack the donor cells. Before transplant, they received a blood purification treatment called protein A immunoadsorption to remove those antibodies, so…
Matched conditions: GRAFT FAILURE
Sponsor: Ting YANG • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Heart transplant patients may soon take just one pill a day
Disease control CompletedThis study tested whether a once-daily version of the anti-rejection drug tacrolimus (Envarsus) works as well as the standard twice-daily version (Prograf) in heart transplant recipients. Fifty adults who had a heart-only transplant were enrolled. The goal was to see if the easie…
Matched conditions: GRAFT FAILURE
Phase: PHASE2 • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC